May 3, 2024
DENVER — With the demand for anti-obesity drugs continuing to soar and the provision of supportive care that is essential with their use lacking, the need […]
May 2, 2024
TOPLINE: In contrast to earlier findings in young lean individuals, dietary n-6 polyunsaturated fat acid (PUFA) doesn’t promote greater lean tissue accumulation than saturated fat acid […]
May 2, 2024
Fish oil supplementation during pregnancy appears to increase the risk for overweight in offspring at age 10 years, new data suggested. However, at least for now, […]
May 1, 2024
ASUNCIÓN, PARAGUAY — The Lancet Diabetes & Endocrinology‘s Commission for the Definition and Diagnosis of Clinical Obesity will soon publish criteria for distinguishing between clinical obesity […]
May 1, 2024
The US Food and Drug Administration has designated the Eversense (Sensionics, Inc; Ascencia Diabetes Care) implanted continuous glucose monitor (CGM) as an “integrated CGM,” meaning it […]
May 1, 2024
TOPLINE: Two days a week of a medically supervised energy-restricted diet may lower blood glucose levels in adults with overweight or obesity and type 2 diabetes […]
May 1, 2024
TOPLINE: Significant misconceptions and potentially maladaptive healthcare beliefs regarding diabetes care were common among individuals with type 2 diabetes (T2D), according to new research. METHODOLOGY: During […]
May 1, 2024
COPENHAGEN (Reuters) – Denmark will start putting patients suffering from type 2 diabetes on cheaper drugs before prescribing so-called GLP-1 drugs such as Novo Nordisk’s Ozempic, […]
April 29, 2024
(Reuters) -The U.S. Food and Drug Administration’s website showed on Monday one dose of Novo Nordisk’s weight-loss drug Wegovy as available after being in short supply, […]